57
53
Growth Score
-11 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
252998
Tract Bio develops targeted therapies for cancer, metaplasia, and inflammatory diseases.
- Richard Russell: Chief Executive Officer & Board MemberPast Role: Minerva Neuroscience, President
- Christopher D Galloway: Chief Medical and Development Officer
About the Company
Tract Bio develops targeted therapies for cancer, metaplasia, and inflammatory diseases. The company builds a robust pipeline of preclinical and clinical assets alone and/or in partnership with established category leaders in cancer and inflammation.
